i-Pharma 2022 will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from the pharma and healthcare industries. The 2-day expo will bring together eminent personalities from various sectors of pharma, non-pharma, and healthcare industries. i-Pharma 2022 is aimed at bringing together all the pharma professionals under one roof, the pharmaceutical exhibition focused on knowledge, technology, and business development. i-Pharma 2022 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution.
i-Pharma 2022 will showcase the latest trends and technologies in pharmaceuticals, drugs, and formulations; direct access to highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration and many more
For more details of floor plan & price quotation contact email@example.com
The global pharmaceuticals market is experiencing persistent growth due to the worldwide increase in life expectancy, as well as the growing incidence of infectious and chronic diseases. The constantly increasing demand for innovative drugs has thus triggered a remarkable rise in R&D investments in the pharmaceuticals industry. The United States is the largest market for pharmaceuticals, accounting for around one-third of the global market and is the world biggest leader in biopharmaceutical R&D. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. The United States solely holds over 45 percent of the global pharmaceutical market. The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and over-the-counter drugs being manufactured. Clinical trials are managed to ensure that products being developed are tested to learn how well they work on individuals affected by the diseases or conditions they are designed to treat. The industry’s main contribution is engaging in technological advancements through innovative research to meet the complex healthcare demands of populations. The global market for pharmaceuticals is anticipated to grow at an annual rate of 4.9% to $1.3 trillion by 2020, and the U.S pharma market is expected to grow to $320 billion by 2020.
The pharmaceutical industry plays a remarkable role in developing medications and vaccines to lessen the incidence of diseases, treat diseases, and strengthen the quality of life of people. Regarding medical research and development, the U.S. has always been a pioneer and a patron of the global pharmaceutical industry. The characteristic that affects the pharmaceutical market size includes disease prevalence, drug affordability, government policies, consumer attitudes, and other supply-side factors. The United States attracts most of the global venture capital investments in start-up biopharmaceutical enterprises. There are more than 800,000 people who work in the biopharmaceutical industry in the United States across a broad range of occupations, including scientific research, technical support, and manufacturing.
Download Exhibitor-Sponsor Catalog from below
Get involved with us along with other related industry experts and stay ahead of the curve. No matter how large or small your marketing budget, you'll benefit from significant sources of visibility from these opportunities.